Liberty All-Star Equity(USA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

USA Liberty All-Star Equity

Market Closed 01-02 16:00:00 EST

6.28

+0.00

0.00%

盘后6.28

+0.000.00%

19:59 EST

High6.34	Low6.22	Vol1.20M
Open6.33	D1 Closing6.28	Amplitude1.91%
Mkt Cap1.85B	Tradable Cap1.85B	Total Shares294.77M
T/O7.47M	T/O Rate0.41%	Tradable Shares294.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"USA","market":"US","secType":"STK","nameCN":"Liberty All-Star Equity","latestPrice":6.28,"timestamp":1767387600000,"preClose":6.28,"halted":0,"volume":1195947,"hourTrading":{"tag":"盘后","latestPrice":6.28,"preClose":6.28,"latestTime":"19:59 EST","volume":383,"amount":2403.565,"timestamp":1767401966354},"delay":0,"floatShares":294774236,"shares":294774236,"eps":0.67848,"marketStatus":"Market Closed","change":0,"latestTime":"01-02 16:00:00 EST","open":6.33,"high":6.34,"low":6.22,"amount":7474784.756859,"amplitude":0.019108,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.67848,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1767603600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":6.28,"dividendRate":0.106704,"preHourTrading":{"tag":"盘前","latestPrice":6.2993,"preClose":6.28,"latestTime":"08:42 EST","volume":91,"amount":569.9892834999999,"timestamp":1767361344990},"postHourTrading":{"tag":"盘后","latestPrice":6.28,"preClose":6.28,"latestTime":"19:59 EST","volume":383,"amount":2403.565,"timestamp":1767401966354},"volumeRatio":0.8636001533050114},"requestUrl":"/m/hq/s/USA/tweets","defaultTab":"tweets","newsList":[{"id":"2595771131","title":"Liberty All-Star Equity Fund President Mark T. Haley Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595771131","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595771131?lang=en_us&edition=fundamental","pubTime":"2025-12-31 02:04","pubTimestamp":1767117894,"startTime":"0","endTime":"0","summary":"Mark T. Haley, President of Liberty All-Star Equity Fund, reported the acquisition of common shares of the Fund, according to a recent regulatory filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liberty All-Star Equity Fund published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL5knGQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Liberty All-Star Equity Fund President Mark T. Haley Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA"],"gpt_icon":0},{"id":"2595792524","title":"InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum","url":"https://stock-news.laohu8.com/highlight/detail?id=2595792524","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595792524?lang=en_us&edition=fundamental","pubTime":"2025-12-30 20:30","pubTimestamp":1767097800,"startTime":"0","endTime":"0","summary":"While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), s","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/30/3211327/0/en/InflaRx-Provides-Update-on-Phase-3-Data-Analyses-for-Vilobelimab-in-Pyoderma-Gangrenosum.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","BK4581","LU0061475181.USD","LU2242652126.USD","LU2129689514.USD","LU0689626769.HKD","USA","LU2552382215.SGD","BK4504","LU0234570918.USD","BK4550","SG9999014559.SGD","SG9999014567.USD","LU0098860793.USD","IE00BN8TJ469.HKD","LU0094547139.USD","BK4558","LU1162221912.USD","LU1914381329.SGD","BK4567","BK4018","LU0868494617.USD","BK4559","LU2129689431.USD","LU0096364046.USD","LU1868837136.USD","SG9999001440.SGD","IE00BBT3K403.USD","LU1929549753.HKD","IE00BWXC8680.SGD","SG9999015358.SGD","LU1430594728.SGD","LU1585245621.USD","IE00B3T34201.USD","BK4588","LU0320765646.SGD","LU2097829019.USD","SG9999015341.SGD","LU0234572021.USD","SG9999002232.USD","LU1868836757.USD","SG9999014542.SGD","PG","LU0640476718.USD","LU2552382132.HKD","LU0124676726.USD","LU0237698245.USD","LU2242646821.SGD","BK4534","BK4533"],"gpt_icon":0},{"id":"2595278099","title":"Press Release: Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2595278099","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595278099?lang=en_us&edition=fundamental","pubTime":"2025-12-29 20:57","pubTimestamp":1767013020,"startTime":"0","endTime":"0","summary":"CHATHAM, N.J., Dec. 29, 2025  -- Tonix Pharmaceuticals Holding Corp.  , a fully-integrated commercial stage biotechnology company, today announced it has entered into a securities purchase agreement with Point72 for the purchase and sale of 615,025 shares of its common stock at an offering price of $16.26 per share and, in lieu of shares of common stock, pre-funded warrants to purchase up to an aggregate of 615,025 shares of common stock at a purchase price of $16.259 per pre-funded warrant, which equals the offering price per share of the common stock less the $0.001 per share exercise price of each pre-funded warrant. The closing of the offering is expected to take place on or about December 30, 2025, subject to the satisfaction of customary closing conditions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4099","CNS","BK4604","TNXP","BK4139","R","USA","BK4022","BK4583","BK4135","BK4588","TM","BK4585","BK4232","BK4555"],"gpt_icon":0},{"id":"2595275834","title":"Tokenization and AI: The emergence of orbital cloud infrastructure | Opinion","url":"https://stock-news.laohu8.com/highlight/detail?id=2595275834","media":"cryptonews","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595275834?lang=en_us&edition=fundamental","pubTime":"2025-12-29 02:04","pubTimestamp":1766945074,"startTime":"0","endTime":"0","summary":"Disclosure: The views and opinions expressed here belong solely to the author and do not represent the views and opinions of crypto.news’ editorial.The global tokenization market size reached approximately $1.24 trillion in 2025, a significant increase from $865.54 billion in 2024, with projections for multi-trillion-dollar growth by the end of the decade. This growth was primarily driven by regulatory clarity in key jurisdictions. This is Part Two of a four-part series where I evaluate key energy requirements to support the growth in AI-driven tokenization necessitating orbital cloud data centers. Part One: 2025 was the year of tokenization. Part Three focuses on energy requirements to support the growth in AI-driven tokenization, necessitating orbital cloud data centers. Part Four focuses on how tokenized edge cloud streaming and AI are transforming sports and prediction markets betting, which is a rapidly developing immersive experience.2025 marked the real-world debut of orbital cl","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/tokenization-emergence-of-orbital-cloud-infrastructure/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/tokenization-emergence-of-orbital-cloud-infrastructure/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["BK4205","AI","LEO","BK4588","BK4587","BK4585","BK4023","BK4233","BK4543","UK","BK4551","BK4528","USA"],"gpt_icon":0},{"id":"2593482074","title":"Press Release: Revival Gold Consolidates Mercur Gold Project by Exercising Option To Acquire 100% of Barrick's Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2593482074","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593482074?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:32","pubTimestamp":1766406720,"startTime":"0","endTime":"0","summary":"TORONTO, Dec. 22, 2025  -- Revival Gold Inc.  , is pleased to announce that it has delivered a notice to exercise its option  to acquire 100% of Barrick Mining Corporation's  interest in the Mercur Gold Project  in Utah, marking a significant step forward on the path to re-starting production. The Option was granted and exercised pursuant to the Mineral Lease and Option to Purchase Agreement dated May 13 , 2021, as amended  among certain wholly owned subsidiaries of the Company and certain affiliates of Barrick.The Option Agreement covers mineral interests amounting to 996 hectares, bringing the total Mercur project area to approximately 7,200 hectares. Revival Gold and its affiliates had previously consolidated ground held by a successor to Homestake Mining Company and various other owners.Revival Gold completed a Preliminary Economic Assessment on the Mercur Gold Project in mid-2025  and undertook a 13,000-meter drill program this year to, among other things, support a planned 2026 p","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAU","RVLGF","SGCmain","USA","1OZmain","BK4017","159934","GDX","NUGT","MGCmain","DUST","SGUmain","518880","GCmain"],"gpt_icon":1},{"id":"2592906641","title":"Global study targets dengue as disease threatens nearly half the world's population","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906641","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906641?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:01","pubTimestamp":1766062860,"startTime":"0","endTime":"0","summary":"LISMORE, Australia, Dec. 18, 2025 /PRNewswire/ -- Thousands of dengue forecasting models have been published, but few have been tested in real public-health settings. Now, researchers from the US and Australia are launching a field evaluation in Vietnam to see whether a new early-warning platform can support earlier interventions against a disease that WHO says puts nearly half the world's population at risk.Southern Cross University is leading the second phase of this multi-year collaboration, working alongside the University of Queensland , Yale University  and Vietnam's National Institute of Hygiene and Epidemiology. This phase has focused on translating predictive modelling into E-Dengue* – an open-source, user-friendly software system tailored for district-level decision-making.Southern Cross University researcher Dr Vinh Bui, said the team's priority has been creating a tool that frontline staff can use in real-world conditions.","market":"sg","thumbnail":"https://i.ytimg.com/vi/WQHN-CMk9Iw/hqdefault.jpg","type":0,"news_type":0,"thumbnails":["https://i.ytimg.com/vi/WQHN-CMk9Iw/hqdefault.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/global-study-targets-dengue-as-disease-threatens-nearly-half-the-worlds-population-302645510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA"],"gpt_icon":0},{"id":"2591825779","title":"Rare Earths Oxide Produced From Halleck Creek Ore","url":"https://stock-news.laohu8.com/highlight/detail?id=2591825779","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591825779?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:03","pubTimestamp":1765890180,"startTime":"0","endTime":"0","summary":"Producing a MREO from Halleck Creek ore, using the updated preliminary PFS mineral processing flowsheet currently being finalized for the upcoming PFS, is the most significant technical milestone achieved for the Project to date. MREO is the precursor used to produce individually separated rare earth products through solvent extraction, such as Neodymium-Praseodymium , Terbium , and Dysprosium . In general, producing MREO is the most challenging technical step in manufacturing separated rare earth oxides. By comparison, the subsequent solvent-extraction stage is a well-established, relatively straightforward process. Next steps in Halleck Creek’s updated preliminary PFS mineral processing flowsheet development include: Solvent extraction simulation","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/16/3206198/0/en/Rare-Earths-Oxide-Produced-From-Halleck-Creek-Ore.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4168","ARRNF","USA"],"gpt_icon":0},{"id":"2591025616","title":"Press Release: Walker Lane Announces Board Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2591025616","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591025616?lang=en_us&edition=fundamental","pubTime":"2025-12-16 16:34","pubTimestamp":1765874040,"startTime":"0","endTime":"0","summary":"VANCOUVER, BC, Dec. 16, 2025 /CNW/ - Walker Lane Resources Ltd.   \"Walker Lane\") announces the resignation of John Land as a Director of the Company and the appointment of Mr. Kevin Brewer, Director and CEO as interim Chairman of the Board.The Board wishes to thank Mr. Land for his significant contribution to the Company.Walker Lane Resources Ltd. is a growth-stage exploration company focused on the exploration of high-grade gold, silver and polymetallic deposits in the Walker Lane Gold Trend District in Nevada and the Rancheria Silver District in Yukon/B.C. and other property assets in Yukon. The Company intends to initiate an aggressive exploration program to advance the Tule Canyon  and Amy  projects through drilling programs with the aim of achieving resource definition in the near future.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA"],"gpt_icon":0},{"id":"2591144629","title":"Liberty All-Star Equity Fund Announces November 2025 Portfolio Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2591144629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591144629?lang=en_us&edition=fundamental","pubTime":"2025-12-16 04:00","pubTimestamp":1765828817,"startTime":"0","endTime":"0","summary":"Liberty All-Star Equity Fund  released its November 2025 monthly update, reporting a large-cap core investment approach with a portfolio managed by three value-style and two growth-style managers. As of November 30, 2025, the top holding in the equity portfolio was NVIDIA Corp. at 4.9%. The top 20 holdings comprised 38.3% of the equity portfolio. Sector allocations included Information Technology at 29.6%, Health Care at 13.8%, Financials at 14.5%, Consumer Discretionary at 11.0%, Industrials at 10.5%, Communication Services at 7.1%, Materials at 4.8%, Consumer Staples at 4.8%, Energy at 2.0%, Utilities at 1.4%, and Real Estate at 0.5%. New holdings in the period included Arch Capital Group, Ltd. and Welltower, Inc., while CarMax, Inc., Commerce Bancshares, Inc., Dexcom, Inc., Trade Desk, Inc., and Zoetis, Inc. were liquidated. The Fund notes that a portion of 2025 distributions may consist of a return of capital, and the final tax characterization will be determined after year-end. Th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDLbJNt1B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDS.UK","BK4579","IE00BQXX3F31.USD","LU1803068979.SGD","IE00BJTD4N35.SGD","SG9999014880.SGD","NVIW.SI","NVDU","LU1066051811.HKD","LU0965509101.SGD","NVD","NVDY","NVDD","SNVD.UK","TTD","LU0097036916.USD","BK4023","IE00BZ1G4Q59.USD","BK4527","LU2420271590.USD","IE00BJJMRY28.SGD","WELL","USA","DXCM","IE0005OL40V9.USD","LU2089284900.SGD","3NVD.UK","NVD2.UK","NVD3.UK","LU2756315664.SGD","BK4214","SG9999014914.USD","LU0868494708.USD","LU1989764664.SGD","LU0316494557.USD","BK4612","ACGL","LU1084165304.USD","BK4614","LU1066051498.USD","LU1989772840.SGD","KMX","CBSH","NVDS","LU0979878070.USD","2NVD.UK","NVDX","ZTS"],"gpt_icon":1},{"id":"2590541590","title":"Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590541590","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590541590?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:05","pubTimestamp":1765487100,"startTime":"0","endTime":"0","summary":"FOSTER CITY, Calif., Dec.  11, 2025  (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced the closing of its pr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3204296/0/en/Terns-Announces-Closing-of-Public-Offering-of-Common-Stock-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TERN","USA"],"gpt_icon":0},{"id":"2590335515","title":"InflaRx Announces International Nonproprietary Name of “Izicopan” for INF904","url":"https://stock-news.laohu8.com/highlight/detail?id=2590335515","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590335515?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:30","pubTimestamp":1765456200,"startTime":"0","endTime":"0","summary":"JENA, Germany, Dec.  11, 2025  (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announce","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3203812/0/en/InflaRx-Announces-International-Nonproprietary-Name-of-Izicopan-for-INF904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INN","BK4181","USA","BK4218"],"gpt_icon":0},{"id":"2590310781","title":"Press Release: Terns Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590310781","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590310781?lang=en_us&edition=fundamental","pubTime":"2025-12-09 19:12","pubTimestamp":1765278720,"startTime":"0","endTime":"0","summary":"FOSTER CITY, Calif., Dec. 09, 2025  -- Terns Pharmaceuticals, Inc.  , a clinical-stage oncology company, today announced that it has commenced a proposed underwritten public offering of $400 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. In addition, Terns expects to grant the underwriters a 30-day option to purchase up to an additional $60 million of shares of common stock offered in the public offering at the public offering price, less underwriting discounts and commissions. All of the shares and pre-funded warrants to be sold in the offering will be offered by Terns. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","USA","TERN"],"gpt_icon":0},{"id":"2590366934","title":"Protara Announces Closing of $75 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590366934","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590366934?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:05","pubTimestamp":1765227900,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec.  08, 2025  (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare d","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/08/3201966/0/en/Protara-Announces-Closing-of-75-Million-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA"],"gpt_icon":0},{"id":"2589355443","title":"American Rare Earths Appoints Mark Wall as Chief Executive Officer to Lead Next Phase of U.S. Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2589355443","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589355443?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:17","pubTimestamp":1765199820,"startTime":"0","endTime":"0","summary":"DENVER, Dec.  08, 2025  (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR”, “American Rare Earths”or the “Company”) is pleased to announce the appointment of Mark W","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/08/3201520/0/en/American-Rare-Earths-Appoints-Mark-Wall-as-Chief-Executive-Officer-to-Lead-Next-Phase-of-U-S-Growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARRNF","BK4107","USA","BK4117","AFG","BK4168"],"gpt_icon":0},{"id":"2589894500","title":"Press Release: Perpetua Further Strengthens Leadership Team as Development of the Stibnite Gold Project Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2589894500","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589894500?lang=en_us&edition=fundamental","pubTime":"2025-12-05 20:00","pubTimestamp":1764936000,"startTime":"0","endTime":"0","summary":"Perpetua brings additional expertise and depth of experience to manage and deliver the Stibnite Gold Project. BOISE, Idaho, Dec. 5, 2025 /PRNewswire/ - Perpetua Resources Corp.   today announced key additions to the Company's leadership team, bringing on accomplished industry leaders as the Company continues Early Works construction of the Stibnite Gold Project ahead of a final investment decision expected in the spring of 2026. Perpetua is excited to welcome Jim Norine as Senior Vice President Projects, Tim Kahl as Senior Vice President Technical Services, Dustin Rissmiller as Vice President Human Resources and Joe Fazzini as Vice President Investor Relations. Collectively, the newest team members bring several decades of expertise and diverse experiences that will help Perpetua bring its gold and antimony project in central Idaho to life.Tim Kahl joins the Company as Senior Vice President Technical Services with over 30 years of experience in design, construction, commissioning, and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGCmain","GCmain","DUST","BK4120","SGCmain","SGUmain","159934","GDX","IAU","TISI","USA","518880","NUGT"],"gpt_icon":1},{"id":"2589830168","title":"Protara Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2589830168","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589830168?lang=en_us&edition=fundamental","pubTime":"2025-12-05 05:15","pubTimestamp":1764882900,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec.  04, 2025  (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/04/3200349/0/en/Protara-Announces-Proposed-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA"],"gpt_icon":0},{"id":"2588004740","title":"Shell plc Announces Final Results of Exchange Offers","url":"https://stock-news.laohu8.com/highlight/detail?id=2588004740","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588004740?lang=en_us&edition=fundamental","pubTime":"2025-12-04 17:46","pubTimestamp":1764841560,"startTime":"0","endTime":"0","summary":"Press Release December 4, 2025 Shell plc Announces Final Results of Exchange Offers Shell plc (“Shell”) (LSE: SHEL) (NYSE: SHEL) (AEX: SHELL) today announces the final results of its previously announ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/04/3199552/0/en/Shell-plc-Announces-Final-Results-of-Exchange-Offers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0724618789.USD","BK4156","LU0055631609.USD","LU0300736492.USD","LU0498741114.HKD","LU0320765646.SGD","BK4585","BK4588","LU0498741890.SGD","SHEL","LU0300736062.USD","LU0788108826.HKD","BK4201","FCA","LU0496367417.USD","LU2236285917.USD","BK4161","B","LU0345780521.USD","LU0330918003.SGD","LU1023059493.AUD","LU0368265764.SGD","LU0345780281.USD","LU0788109121.HKD","BK4017","LU0075056555.USD","LU0098860793.USD","USA","LU1162221912.USD","LU0278409577.USD"],"gpt_icon":0},{"id":"2588002401","title":"Dr. Darin Phanthusak: Redefining Leadership, Empowerment, and Global Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2588002401","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588002401?lang=en_us&edition=fundamental","pubTime":"2025-12-04 17:00","pubTimestamp":1764838800,"startTime":"0","endTime":"0","summary":"BANGKOK, Dec. 4, 2025 /PRNewswire/ -- Dr. Darin Phanthusak, Vice President of Tiffany's Show Pattaya, was recently recognized with the Master Entrepreneur Award at the Asia Pacific Enterprise Awards  2025organized by Enterprise Asia, honoring her visionary leadership and contributions to both business and society.The recognition marks another milestone in Dr. Darin's remarkable journey—one defined by growth, inclusion, and purpose. As the driving force behind Tiffany's Show Pattaya, the Asia's first and premier cabaret show featuring diverse performers, she has preserved a world-renowned legacy while transforming it into a global platform for empowerment and diversity.Her passion for leadership and innovation led to her co-authoring the international publication Unboss  with Lars Kolind, former Chairman of the World Scout Foundation. Her growing influence across industries and communities has earned her significant recognition—she was named one of Howe Magazine's 50 Most Influential Pe","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/dr-darin-phanthusak-redefining-leadership-empowerment-and-global-impact-302632826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA"],"gpt_icon":0},{"id":"2588727630","title":"ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive Early Endpoint in Alzheimer’s trials, Supporting its Ongoing Phase 1b PRECISE-AD trial with PMN310","url":"https://stock-news.laohu8.com/highlight/detail?id=2588727630","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588727630?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:30","pubTimestamp":1764592200,"startTime":"0","endTime":"0","summary":"Cross-trial analysis supports plasma pTau as a potential early predictor of clinical benefit, reinforcing the biomarker-driven design of ProMIS’ PRECISE-AD trial ProMIS on track to leverage new plasma","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/01/3196921/0/en/ProMIS-Neurosciences-Announces-New-Peer-Reviewed-Publication-Showing-Plasma-pTau-as-a-Predictive-Early-Endpoint-in-Alzheimer-s-trials-Supporting-its-Ongoing-Phase-1b-PRECISE-AD-tri.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AD","BK4170","MSA","BK4143","LU2211815571.USD","LU2125909759.SGD","BK4132","LU0053671581.USD","LU2125909916.SGD","LU1169589451.USD","LU1815336091.USD","LU1923622291.USD","LU0728928796.USD","BK4595","ARIA","BK4526","LU0757428866.USD","LU1169590202.USD","BK4600","USA","BK4023","PD"],"gpt_icon":1},{"id":"2588223137","title":"ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2588223137","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588223137?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:00","pubTimestamp":1764590400,"startTime":"0","endTime":"0","summary":"Cambridge, Massachusetts, Dec.  01, 2025  (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s dise","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/01/3196854/0/en/ProMIS-Neurosciences-to-Participate-in-the-8th-Annual-Evercore-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","LU2211815571.USD","LU0728928796.USD","BK4137","LU1923622291.USD","LU1815336091.USD","BK4585","BK4588","BK4595","BK4023","XBI","LU0029874061.USD","BK4143","ARIA","BK4218","XLV","AD","LU2125909916.SGD","LU2125909759.SGD","BK4526","BK4581","MSA","LU0128526141.USD","BK4600","LU0757428866.USD","LABU","LU1169589451.USD","PK","LU0053671581.USD","PD","LU1169590202.USD","HCSG","BK4170","USA","BK4181"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.all-starfunds.com","stockEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":0.0228},{"period":"3month","weight":-0.0294},{"period":"6month","weight":-0.0951},{"period":"1year","weight":-0.1029},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0103},{"period":"1month","weight":-0.0011},{"period":"3month","weight":0.0209},{"period":"6month","weight":0.0925},{"period":"1year","weight":0.1685},{"period":"ytd","weight":0.0018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Liberty All Star Equity Fund is a closed-ended equity mutual fund launched and managed by ALPS Advisers, Inc. The fund is co-managed by Aristotle Capital Management, LLC, Pzena Investment Management, LLC, Delaware Investments Fund Advisers, Sustainable Growth Advisers, LP, and TCW Investment Management Company. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value and growth stocks of large cap companies. The fund benchmarks the performance of its portfolio against the Lipper Large-Cap Core Mutual Fund Average, the Dow Jones Industrial Average, the NASDAQ Composite Index, and the S&P 500 Index. Liberty All Star Equity Fund was formed on October 31, 1986 and is domiciled in the United States.","yearOnYearQuotes":[{"month":1,"riseRate":0.55,"avgChangeRate":0.011538},{"month":2,"riseRate":0.487179,"avgChangeRate":0.000057},{"month":3,"riseRate":0.564103,"avgChangeRate":0.00273},{"month":4,"riseRate":0.538462,"avgChangeRate":0.00974},{"month":5,"riseRate":0.538462,"avgChangeRate":-0.0042},{"month":6,"riseRate":0.538462,"avgChangeRate":0.005641},{"month":7,"riseRate":0.538462,"avgChangeRate":0.008018},{"month":8,"riseRate":0.410256,"avgChangeRate":-0.020782},{"month":9,"riseRate":0.461538,"avgChangeRate":-0.009212},{"month":10,"riseRate":0.487179,"avgChangeRate":-0.003123},{"month":11,"riseRate":0.6,"avgChangeRate":-0.00139},{"month":12,"riseRate":0.625,"avgChangeRate":0.007434}],"exchange":"NYSE","name":"Liberty All-Star Equity","nameEN":"Liberty All-Star Equity"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liberty All-Star Equity(USA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liberty All-Star Equity(USA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liberty All-Star Equity,USA,Liberty All-Star Equity股票,Liberty All-Star Equity股票老虎,Liberty All-Star Equity股票老虎国际,Liberty All-Star Equity行情,Liberty All-Star Equity股票行情,Liberty All-Star Equity股价,Liberty All-Star Equity股市,Liberty All-Star Equity股票价格,Liberty All-Star Equity股票交易,Liberty All-Star Equity股票购买,Liberty All-Star Equity股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liberty All-Star Equity(USA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liberty All-Star Equity(USA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction